series-c-plus
Stage
1
Investors
About
Perahealth develops the Rothman Index, an FDA-cleared AI-driven predictive analytics system that analyzes clinical data to help clinicians detect patient deterioration early and improve patient outcomes.
Explore Perahealth's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.